İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2006 · article

Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations.

ISSN0161-6412
YÖKSİS OpenAlex Üst %10
Yıl2006
Atıf48OpenAlex
Yüzdelik%90,3
FWCI2,941,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıNEUROLOGICAL RESEARCH
  • Katalog eşleşmesi (ISSN)Neurological Research
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

OBJECTIVE: The aim of this study was to determine whether hyperhomocysteinemia caused by levodopa used in idiopathic Parkinson's disease (IPD) is associated with cognitive or physical impairments. The role of folate and vitamin B12 levels in this context was also ascertained. METHODS: Thirty-nine patients who had been followed with the diagnosis of IPD in our clinic for > 2 years and 28 healthy control subjects with similar demographic features were included in the study. The homocysteine, folic acid and vitamin B12 levels and the results of the short test of mental status (STMS) and the clock drawing test of IPD patients were compared with those of the controls. Subsequently, the patients with a homocysteine level of >14 micromol/l were compared with those having a homocysteine level of <14 micromol/l by means of detailed neuropsychometric test batteries. RESULTS: Homocysteine levels were significantly higher in the patient group in comparison with the controls. There was a negative correlation between hyperhomocysteinemia and the levels of vitamin B12 and folate. On the other hand, a positive correlation between hyperhomocysteinemia and the levodopa dose was detected. There was a positive correlation between hyperhomocysteinemia and unified Parkinson's disease rating scale (UPDRS) motor section. The critical dose of levodopa was observed to be 300 mg/d. In terms of cognitive and frontal functions, no significant difference was detected between the patients and control group. The subgroup with a homocysteine level of >14 micromol/l had a significantly poorer performance in frontal and memory tests. DISCUSSION: In patients with IPD who are detected to have hyperhomocysteinemia, the assessment of the cognitive performance, folic acid and vitamin B12 levels and the supplementation of folic acid and vitamin B12 to the treatment regimen might be appropriate.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

48atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 5 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2016 The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson’s DiseaseAtıf 14 · OpenAlex
  2. 2021 How Does Entacapon Affect Homocysteine Levels?Atıf 1 · OpenAlex
  3. 2021 How Does Entacapon Affect Homocysteine Levels?Atıf 1 · OpenAlex
  4. 2021 How Does Entacapon Affect Homocysteine Levels?Atıf 1 · OpenAlex
  5. 2024 Effects of Vitamins on Some Neurological DiseasesAtıf 0 · OpenAlex

Yazarlar

9
  1. FAHRİYE FERİHA ÖZER 1
  2. HASAN MERAL 2
  3. LÜTFÜ HANOĞLU İSTANBUL MEDİPOL ÜNİVERSİTESİ 3
  4. TUBA AYDEMİR 4
  5. MERAL YİLSEN 5
  6. SİBEL ÇETİN 6
  7. OYA ÖZTÜRK 7
  8. HATİCE SEVAL 8
  9. MACİT KOLDAŞ 9